Health and pharmaceuticals

Designing intelligent health systems and advancing the future of medicine.

Talk to our team

Advancing better health outcomes for more people, at sustainable cost

Scientific progress is expanding what medicine can achieve, while demographic change and rising expectations are increasing the demands placed on health systems. Leaders must connect innovation with delivery, balancing scientific complexity, system sustainability, and patient needs as AI, advanced therapies, and connected technologies reshape medicine, public health, and care.

The future of health will be defined by the ability to translate scientific and digital innovation into better outcomes for individuals and entire populations.

What’s reshaping health and pharmaceuticals?

The choices ahead are sharper: where to lead the science, where to redesign the system, and where to build the next engine of growth.

Innovation is becoming more precise.

Advanced therapies, precision medicine, and biology-driven R&D are transforming treatment pathways and demanding new operating, commercial, and regulatory models.

AI is transforming discovery, care delivery, and health management.

AI is accelerating discovery, sharpening trial design, strengthening manufacturing and supply chains, and enabling earlier intervention, more personalized care, and better population health insights.

Health is shifting from episodic care to continuous health management.

Prevention, early detection, population health, and long-term disease management are reshaping where value is created across patients, providers, payers, policymakers, and communities.

From treatment pathways to intelligent health systems

Leading organizations are moving beyond fragmented initiatives and incremental digitization to connect science, public health, care delivery, and policy through integrated health ecosystems.

The next stage of health leadership will belong to organizations that can turn scientific and digital innovation into accessible, trusted, outcomes-focused care for individuals and populations.

Why Strategy&

Strategy& partners with pharmaceutical and biotech leaders, life sciences innovators, healthcare providers, public health organizations, ministries of health, and health system leaders on the strategic choices shaping the future of health.

We connect strategy with the scientific, operational, policy, and system decisions that improve health outcomes.

1

Health and life sciences expertise

We advise leading life sciences and healthcare organizations on consequential decisions involving scientific innovation, patient outcomes, population health, system sustainability, and regulatory navigation.

2

Strategy through health impact

We work alongside leadership teams to translate ambition into measurable outcomes across science, patients, populations, access, and trust.

3

Analytics and AI for responsible adoption

We embed advanced analytics and AI across our work to accelerate discovery, personalize care, strengthen supply integrity, improve population health insights, and build the trust required for responsible adoption.

Our services

We work across the health and life sciences landscape, from setting scientific, public health, and system ambitions to making the operational, technological, policy, and regulatory decisions that bring them to life.

01.

Public health strategy and system resilience

Design national health strategies, strengthen public health systems, improve prevention, preparedness, workforce planning, and health equity, and build resilient systems that deliver sustainable outcomes for populations.

02.

Pharmaceuticals strategy and commercialization

Reshape pharmaceutical strategy, portfolios, and commercialization models to capture value from precision medicine, AI-led innovation, and outcome-based growth.

03.

Biotechnology strategy and scale-up

Shape biotech strategy from discovery through scale-up, translating scientific breakthroughs into commercially viable, sustainable, and globally accessible therapies.

04.

Life sciences value chain and operations

Strengthen life sciences value chains, from R&D and clinical development to supply chains, manufacturing, and regulatory readiness, to create a more resilient, intelligent, and patient-centered sector.

05.

Health systems and provider transformation

Redesign health systems, provider organizations, and care models to deliver better outcomes, greater access, and more sustainable health systems in an AI-enabled era.